FDA
-
-
-
-
-
-
-
Number of shares and votes in Oncopeptides
-
-
-
-
-
-
-
Oncopeptides initiates the first study with melflufen outside multiple myeloma and enrolls the first patient in the phase 1/2 AL amyloidosis study
-
-
-
-
-
-
-
Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)
324,042 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

